RWB
CTIC

RMR Wealth Builders’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

RMR Wealth Builders’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Buy
+10
New +$9 ﹤0.01% 422

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RMR Wealth Builders's CTIC Position: Q4 2019 in Review

RMR Wealth Builders opened a new position in CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2019: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #422 among its holdings.

40 funds tracked by Wall St. Rank hold CTIC as of Q4 2019.

  • RMR Wealth Builders held 10 shares of CTI BioPharma Corp. (DE) Common Stock worth $0 as of Q4 2019.
  • CTI BioPharma Corp. (DE) Common Stock was a new RMR Wealth Builders position in Q4 2019.
  • CTI BioPharma Corp. (DE) Common Stock made up ﹤0.01% of RMR Wealth Builders's portfolio in Q4 2019, its #422 holding.
  • 40 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2019.

Based on RMR Wealth Builders's 13F filing for Q4 2019, filed 3 Mar 2020.